Nokea
The nurse applies the nursing process in medication therapy to ensure what?
- A. That medications are given at the right time
- B. That care is efficient and effective
- C. That the right dose of the drug is given to the patient
- D. That the right drug is given to the right patient at the right time
Correct Answer: B
Rationale: The nursing process ensures efficient, effective care, encompassing all aspects of safe administration.
You may also like to solve these questions
The standard dosage of St John's wort for the treatment of mild depression is:
- A. 300 mg daily
- B. 100 mg three times a day
- C. 300 mg three times a day
- D. 600 mg three times a day
Correct Answer: C
Rationale: 300 mg three times daily is the standard dose for St John's wort in mild depression.
Ipratropium bromide is
- A. Bronchoselective anticholinergic
- B. Used as mydriatic
- C. A selective MI anticholinergic useful in peptic ulcer
- D. An antiparkinsonism drug
Correct Answer: A
Rationale: Ipratropium is a bronchoselective anticholinergic used in COPD/asthma.
Which of the following names may be assigned to a drug during the process of development? (Select one that does not apply.)
- A. Chemical name
- B. Official name
- C. Pharmacologic name
- D. Trade name
Correct Answer: C
Rationale: Throughout the process of development, drugs may have several names assigned to them including a chemical name, a generic (nonproprietary) name, an official name, and a trade or brand name.
The study of dose, distribution, metabolism & excretion of drugs in the body is known as
- A. Pharmacognosia
- B. Pharmacodynamics
- C. Dose effective study
- D. Pharmacotherapy
Correct Answer: B
Rationale: Pharmacodynamics studies drug effects, but pharmacokinetics (dose, distribution, metabolism, excretion) is more specific here; likely a typo in the document.
A newly developed medication for pulmonary hypertension targets blood vessels in the lungs, but does not affect blood vessels in the liver. Which of the following is most likely true of this medication?
- A. It is a ligand that is specific for lung and liver blood-vessel receptors. but which is metabolized rapidly in the liver
- B. It is a ligand that is specific for blood-vessel receptors in the lung but not in the liver
- C. It is a receptor that is upregulated when oxygen tension in the lungs is low
- D. It is a receptor that is only expressed on blood vessels in the lungs
Correct Answer: B
Rationale: The medication's specificity for lung blood vessels suggests it targets receptors unique to that tissue, not the liver.